Results
35
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
35 companies
Novartis
Market Cap: CHF 184.8b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 95.47
7D
0.8%
1Y
2.3%
Merck
Market Cap: US$200.5b
Operates as a healthcare company worldwide.
MRK
US$80.79
7D
-2.2%
1Y
-27.3%
Waters
Market Cap: US$17.0b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$281.19
7D
-7.3%
1Y
-15.0%
Orion Oyj
Market Cap: €10.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€71.40
7D
1.2%
1Y
67.1%
Abbott India
Market Cap: ₹706.8b
Operates as a pharmaceutical company in India.
500488
₹33,260.70
7D
-4.2%
1Y
19.6%
SK Biopharmaceuticals
Market Cap: ₩8.7t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩111,400.00
7D
10.4%
1Y
40.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹481.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,840.30
7D
-9.7%
1Y
1.9%
Xiamen Amoytop Biotech
Market Cap: CN¥36.0b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥88.40
7D
14.3%
1Y
71.3%
Agios Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$36.21
7D
-4.0%
1Y
-15.0%
BioArctic
Market Cap: SEK 19.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 222.60
7D
5.6%
1Y
41.8%
Blue Jet Healthcare
Market Cap: ₹137.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹791.50
7D
-1.5%
1Y
68.3%
Sanofi India
Market Cap: ₹125.0b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹5,428.70
7D
-6.7%
1Y
-16.4%
Neuren Pharmaceuticals
Market Cap: AU$2.1b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$16.94
7D
1.4%
1Y
-0.9%
Procter & Gamble Health
Market Cap: ₹102.7b
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
500126
₹6,185.55
7D
4.1%
1Y
19.5%
Philogen
Market Cap: €887.3m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.
PHIL
€22.00
7D
-2.2%
1Y
5.8%
Jeena Sikho Lifecare
Market Cap: ₹71.2b
Trades in ayurvedic medicines in India.
JSLL
₹573.05
7D
3.2%
1Y
163.4%
L&C BIOLTD
Market Cap: ₩779.2b
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩31,650.00
7D
-10.0%
1Y
79.2%
Ever Supreme Bio Technology
Market Cap: NT$13.8b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$157.50
7D
2.6%
1Y
-1.3%
RPG Life Sciences
Market Cap: ₹38.6b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,331.20
7D
3.2%
1Y
23.7%
PharmaEngine
Market Cap: NT$11.5b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$79.70
7D
4.7%
1Y
-1.4%
Puma Biotechnology
Market Cap: US$157.8m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.22
7D
1.3%
1Y
-20.1%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft35.6b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,580.00
7D
2.4%
1Y
n/a
Ind-Swift Laboratories
Market Cap: ₹7.8b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹102.09
7D
-3.5%
1Y
-39.1%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.3b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م651.70
7D
15.3%
1Y
197.3%
Fidson Healthcare
Market Cap: ₦100.8b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦43.90
7D
0%
1Y
219.3%
EZZ Life Science Holdings
Market Cap: AU$98.1m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.08
7D
-4.6%
1Y
17.5%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.9b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م196.77
7D
0.3%
1Y
181.1%
JW Shinyak
Market Cap: ₩84.2b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,583.00
7D
-1.9%
1Y
0.7%
Influx Healthtech
Market Cap: ₹3.6b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹153.95
7D
-2.6%
1Y
n/a
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.0t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫107,900.00
7D
2.3%
1Y
28.5%
Arab Drug
Market Cap: ج.م1.6b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م131.97
7D
0.008%
1Y
221.9%
Celemics
Market Cap: ₩26.5b
Designs, manufactures, and distributes sequencing kits in South Korea.
A331920
₩3,245.00
7D
2.0%
1Y
-8.8%
Asston Pharmaceuticals
Market Cap: ₹1.0b
Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.
544445
₹119.50
7D
1.5%
1Y
n/a
Genesis IBRC India
Market Cap: ₹387.7m
Does not have significant operations.
514336
₹29.82
7D
5.0%
1Y
n/a
Scinai Immunotherapeutics
Market Cap: US$1.4m
A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
SCNI
US$1.60
7D
-20.0%
1Y
-55.2%